Abstract
Abnormal protein aggregation is a common characteristic of many neurodegenerative diseases of the brain. Filamentous deposits made of the microtubule-associated protein tau constitute a major defining characteristic of several neurodegenerative diseases known as tauopathies. The role of tau in neurodegeneration has been clarified by the identification of genetic mutations in the tau gene in cases with familial frontotemporal dementia and parkinsonism linked to chromosome 17. Furthermore, some sporadic tauopathies are associated with tau gene polymorphisms. Although it is still debated how tau gene mutations lead to neuronal death, it is clear that different mutations lead to tau pathologies with characteristics similar to those found in sporadic tauopathies. These findings have definitely shown that in tauopathies tau aggregation is directly associated with development of neurodegeneration and neuronal death.
Similar content being viewed by others
References
Andreadis A., Brown W. M., and Kosik K. S. (1992) Structure and novel exons of the human tau gene. Biochemistry 31, 10626–10633.
Allen B., Ingram E., Takao M., et al. (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340–9351.
Baker M., Graff-Radford D., Wavrant DeVrieze F., et al. (2000) No association between TAU haplotype and Alzheimer’s disease in population or clinic based series or in familial disease. Neurosci. Lett. 285, 147–149.
Baker M., Litvan I., Houlden H., et al. (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711–715.
Bennett P., Bonifati V., Bonuccelli U., et al. (1998) Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. Neurology 51, 982–985.
Berriman J., Serpell L. C., Oberg K. A., et al. (2003) Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure. Proc. Natl. Acad. Sci. USA 100, 9034–9038.
Bird T. D., Nochlin D., Poorkaj P., et al. (1999) A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) Brain 122, 741–756.
Bugiani O., Murrell J. R., Giaccone G., et al. (1999) Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropathol. Exp. Neurol. 58, 667–677.
Bullido M. J., Aldudo J., Frank A., et al. (2000) A polymorphism in the tau gene associated with risk for Alzheimer’s disease. Neurosci. Lett. 278, 49–52.
Clark L. N., Poorkaj P., Wszolek Z., et al. (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc. Natl. Acad. Sci. USA 95, 13103–13107.
Conrad C., Andreadis A., Trojanowski J. Q., et al. (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol. 41, 277–281
Crawford F., Freeman M., Town T., et al. (1999) No genetic association between polymorphisms in the Tau gene and Alzheimer’s disease in clinic or population based samples. Neurosci. Lett. 266, 193–196.
Dayanandan R., Van Slegtenhorst M., Mack T. G., et al. (1999) Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett. 446, 228–232.
Delisle M. B., Murrell J. R., Richardson R., et al. (1999) A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathol. (Berl.) 98, 62–77.
De Silva R., Weiler M., Morris H. R., et al. (2000) Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. Neurosci. Lett. 311, 145–148.
Di Maria E., Tabaton M., Vigo T., et al. (2000) Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann. Neurol. 47, 374–377.
Duda J. E., Giasson B. I., Mabon M. E., et al. (2001) Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol. (Berl.) 104, 7–11.
D’Souza I. and Schellenberg G. D. (2002) tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5′ and 3′ splice sites. J. Biol. Chem. 277, 26587–26599.
D’Souza I., Poorkaj P., Hong M., et al. (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. USA 1999;965, 598–603.
Ebneth A., Godemann R., Stamer K., et al. (1998) Over-expression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer’s disease. J. Cell Biol. 143, 777–794.
Ezquerra M., Pastor P., Valldeoriola F., et al. (1999) Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans. Neurosci. Lett. 275, 183–186.
Ghetti B., Piccardo P., Spillantini M. G., et al. (1996) Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc. Natl. Acad. Sci. 93, 744–748.
Goedert M., Spillantini M. G., Serpell L. C., et al. (2001) From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. Phil. Trans. R Soc. Lond. B Biol. Sci. 356, 213–227.
Goedert M., Jakes R., and Crowther R. A. (1999a) Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 450, 306–311.
Goedert M., Spillantini M. G., Crowther R. A., et al. (1999b) Tau gene mutation in familial progressive subcortical gliosis. Nat. Med. 5, 454–457.
Goedert M., Jakes R., Spillantini M. G., et al. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550–553.
Goedert M., Spillantini M. G., Potier M. C., Ulrich J., and Crowther R. A. (1989a) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8, 393–399.
Goedert M., Spillantini M. G., Jakes R., Rutherford D., and Crowther R. A. (1989b) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3, 519–526.
Goode B. L. and Feinstein S. C. (1994) Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. J. Cell Biol. 124, 769–782.
Götz J., Probst A., Spillantini M.G., et al. (1995) Somatodendritic localisation and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J. 14, 1304–1313.
Green E. K., Thaker U., McDonagh A. M., et al. (2002) A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer’s disease, nor does it influence the extent of tau pathology in the brain. Neurosci. Lett. 324, 113–116.
Grover A., DeTure M., Yen S. H., Hutton M. (2002) Effects on splicing and protein function of three mutations in codon N296 of tau in vitro. Neurosci. Lett. 323, 33–36.
Grover A., Houlden H., Baker M., et al. (1999) 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J. Biol. Chem. 274, 15134–15143.
Harada A., Oguchi K., Okabe S., et al. (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369, 488–491.
Hasegawa M., Smith M. J., Iijima M., Tabira T., and Goedert M. (1999) FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett. 443, 93–96.
Hasegawa M., Smith M. J., and Goedert M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207–210.
Hayashi S., Toyoshima Y., Hasegawa M., et al. (2002) Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann. Neurol. 51, 525–530.
Heutink P., Stevens M., Rizzu P., et al. (1997) Hereditary frontotemporal dementia is linked to chromosome 17q21-q22, a genetic and clinicopathological study of three Dutch families. Ann. Neurol. 41, 150–159.
Higgins J. J., Litvan I., Pho L. T., Li W., and Nee L. E. (1998) Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology 50, 270–273.
Hirokawa N. (1994) Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr. Opin. Cell Biol. 6, 74–81.
Hoenicka J., Perez M., Perez-Tur J., et al. (1999) The tau gene A0 allele and progressive supranuclear palsy. Neurology 53, 1219–1225.
Holton J. L., Ghiso J., Lashley T., et al. (2001) Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am. J. Pathol. 15, 515–526.
Hong M., Zhukareva V., Vogelsberg-Ragaglia V., et al. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914–1917.
Houlden H., Baker M., Morris H. R., et al. (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56, 1702–1706.
Hughes A., Mann D., Pickering-Brown S. (2003) Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Exp. Neurol. 181, 12–16.
Hulette C. M., Pericak-Vance M. A., Roses A. D., et al. (1999) Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke Family 1684. J. Neuropathol. Exp. Neurol. 58, 859–866.
Hutton M., Lewis J., Dickson D., Yen S. H., and McGowan E. (2001) Analysis of tauopathies with transgenic mice. Trends Mol. Med. 7, 467–470.
Hutton M., Lendon C. L., Rizzu P., et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–5.
Iijima M., Tabira T., Poorkaj P., et al. (1999) A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 10, 497–501.
Ingelson M., Fabre S. F., Lilius L., et al. (2001) Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. Neuroreport 12, 905–909.
Iseki E., Matsumura T., Marui W., et al. (2001) Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells. Acta Neuropathol. (Berl). 102, 285–292.
Kobayashi T., Ota S., Tanaka K., et al. (2003) A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology. Ann. Neurol. 53, 133–137.
Kwon J. M., Nowotny P., Shah P. K., et al. (2000) Tau polymorphisms are not associated with Alzheimer’s disease. Neurosci. Lett. 284, 77–80.
Lee V. M.-Y., Goedert M., and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121–1159.
Lilius L., Froelich Fabre S., Basun H., et al. (1999) Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer’s disease. Neurosci. Lett. 277, 29–32.
Lippa C. F., Zhukareva V., Kawarai T., et al. (2000) Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation. Ann. Neurol. 48, 850–858.
Lossos A., Reches A., Gal A., et al. (2003) Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family. J. Neurol. 250, 733–740.
Makrides V., Shen T. E., Bhatia R., et al. (2003) Microtubule dependent oligomerization of tau: Implications for physiological tau function and tauopathies. J. Biol. Chem. 278, 33,298–33,304.
Matsumura N., Yamazaki T., and Ihara Y. (1999) Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Am. J. Pathol. 154, 1649–1656.
Morris H. R., Baker M., Yasojima K., et al. (2002) Analysis of tau haplotypes in Pick’s disease. Neurology 59, 443–445.
Morris H. R., Janssen J. C., Bandmann O., et al. (1999) The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 66, 665–667.
Mirra S. S., Murrell J. R., Gearing M., et al. (1999) Tau pathology in a family with dementia and a P301L mutation in tau. J. Neuropathol. Exp. Neurol. 58, 335–345.
Miyamoto K., Kowalska A., Hasegawa M., et al. (2001) Familial frontotemporal dementia and parkinsonism with a novel mutation at an intron 10+11-splice site in the tau gene. Ann. Neurol. 2001; 50, 117–120.
Murrell J. R., Spillantini M. G., Zolo P., et al. (1999) Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. J. Neuropathol. Exp. Neurol. 58, 1207–1226.
Nacharaju P., Lewis J., Easson C., et al. (1999) Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett. 447, 195–199.
Neumann M., Schulz-Schaeffer W., Crowther R. A., et al. (2001) Pick’s disease associated with the novel Tau gene mutation K369I. Ann. Neurol. 50, 503–513.
Oliva R., Tolosa E., Ezquerra M., et al. (1998) Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch. Neurol. 55, 1122–1124.
Panegyres P. K. and Zafiris-Toufexis K. (2002) Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. Eur. J. Neurol. 9, 485–489.
Pickering-Brown S. M., Richardson A. M., Snowden J. S., et al. (2002) Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain 125, 732–751.
Pickering-Brown S., Baker M., Yen S. H., et al. (2000) Pick’s disease is associated with mutations in the tau gene. Ann. Neurol. 48, 859–867.
Poorkaj P., Muma N. A., Zhukareva V., et al. (2002) An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol. 52, 511–516.
Poorkaj P., Tsuang D., Wijsman E., et al. (2001) TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam. Arch. Neurol. 58, 1871–1878.
Poorkaj P., Bird T. D., Wijsman E., et al. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol. 43, 815–825. [Published erratum appears in: Ann. Neurol. 44, 428, 1998.]
Reed L. A., Schmidt M. L., Wszolek Z. K., et al. (1998) The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia (“pallido-ponto-nigral degeneration”). J. Neuropathol. Exp. Neurol. 57, 588–601.
Reed L. A., Grabowski T. J., Schmidt M. L., et al. (1997) Autosomal dominant dementia with widespread neurofibrillary tangles. Ann. Neurol. 42, 564–572.
Rizzini C., Goedert M., Hodges J. R., et al (2000) Tau gene mutation K257T causes a tauopathy similar to Pick’s disease. J. Neuropathol. Exp. Neurol. 59, 990–1001.
Rosso S. M. and van Swieten J. C. (2002a) New developments in frontotemporal dementia and parkinsonism linked to chromosome 17. Curr. Opin. Neurol. 15, 423–428.
Rosso S. M., van Herpen E., Deelen W., et al. (2002b) A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick’s disease. Ann. Neurol. 5, 373–376.
Russ C., Powell J. F., Zhao J., et al. (2001a) The microtubule associated protein Tau gene and Alzheimer’s disease—an association study and meta-analysis. Neurosci. Lett. 314, 92–96.
Russ C., Lovestone S., Baker M., et al. (2001b) The extended haplotype of the microtubule associated protein tau gene is not associated with Pick’s disease. Neurosci. Lett. 299, 156–158.
Short R. A., Graff-Radford N. R., Adamson J., Baker M., and Hutton M. (2002) Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch. Neurol. 59, 611–615.
Sobrido M. J., Abu-Khalil A., Weintraub S., et al. (2003a) Possible association of the tau H1/H1 genotype with primary progressive aphasia. Neurology 60, 862–864.
Sobrido M. J., Miller B. L., Havlioglu N., et al. (2003b) Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Arch. Neurol. 60, 698–702.
Spillantini M. G., Yoshida H., Rizzini C., et al. (2000) A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann. Neurol. 48, 939–943.
Spillantini M. G., Crowther R. A., Kamphorst W., Heutink P., and van Swieten J. C. (1998a) Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am. J. Pathol. 153, 1359–1363.
Spillantini M. G., Murrell J. R., Goedert M., et al. (1998b) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737–7741.
Spillantini M. G., Bird T., and Ghetti B. (1998c) Frontotemporal dementia and parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol. 8, 387–402.
Spillantini M. G., Goedert M., Crowther R. A., et al. (1997) Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc. Natl. Acad. Sci. USA 94, 4113–4118.
Spillantini M. G., Crowther R. A., and Goedert M. (1996) Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles. Acta. Neuropathol. (Berl.) 92, 42–48.
Stanford P. M., Shepherd C. E., Halliday G. M., et al. (2003) Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 126, 814–826.
Stanford P. M., Halliday G. M., Brooks W. S., et al. (2000) Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain 123, 880–893.
Sumi S. M., Bird T. D., Nochlin D., and Raskind M. A. (1992) Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurology 42, 120–127.
Tsuboi Y., Baker M., Hutton M. L., et al. (2002) Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology 59, 1791–1793.
Van Herpen E., Rosso, S. M., Severijnen, L. A., et al. (2003) Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Ann. Neurol., in press.
Van Swieten J. C., Stevens M., Rosso S. M., et al. (1999) Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann. Neurol. 46, 617–626.
Varani L., Hasegawa M., Spillantini M. G., et al. (1999) Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc. Natl. Acad. Sci. USA 96, 8229–8234.
Verpillat P., Camuzat A., Hannequin D., et al. (2002) Association between the extended tau haplotype and frontotemporal dementia. Arch. Neurol. 59, 935–939.
Von Bergen M., Barghorn S., Li L., et al. (2001) Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J. Biol. Chem. 276, 48165–48174.
Yasuda M., Takamatsu J., D’Souza I., et al. (2000) A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto) Ann. Neurol. 47, 422–429.
Yoshida H., Crowther R. A., and Goedert M. (2002) Functional effects of tau gene mutations deltaN296 and N296H. J. Neurochem. 80, 548–551.
Zhukareva V., Sundarraj S., Mann D., et al. (2003) Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta. Neuropathol. (Berl.) 105, 469–476.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yancopoulou, D., Spillantini, M.G. Tau protein in familial and sporadic diseases. Neuromol Med 4, 37–48 (2003). https://doi.org/10.1385/NMM:4:1-2:37
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/NMM:4:1-2:37